Impact of Metformin Versus the Prandial Insulin Secretagogue, Repaglinide, on Fasting and Postprandial Glucose and Lipid Responses in Non-Obese Patients With Type 2 Diabetes
European Journal of Endocrinology - United Kingdom
doi 10.1530/eje-07-0500e1
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2011
Authors
Publisher
Bioscientifica